At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m (1) TP).
Bayer's agrochemicals unit Monsanto has filed lawsuits in the US against the manufacturers of mRNA-based COVID-19 vaccines, ...
Frankfurt: German agrichemical giant Bayer confirmed to AFP on Wednesday that it was suing American pharmaceutical firms ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹?TP). The ...
Foundation-funded project targets infectious bronchitis and infectious laryngotracheitis viruses.
The Manila Times on MSN
Bayer sues COVID vaccine makers over mRNA technology
Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for ...
Bayer has filed patent infringement lawsuits against COVID-19 vaccine makers Pfizer, BioNTech, Moderna, and Johnson & Johnson ...
MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.
Covid vaccine makers Pfizer, BioNTech and Moderna are being sued for allegedly copying messenger RNA (mRNA) technology ...
Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID vaccines.
Last week, biotechnology company Ascidian Therapeutics announced a manufacturing partnership with gene-therapy–focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results